{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:18:33Z","timestamp":1788185913666,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12185-026-04212-3","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:35:25Z","timestamp":1776872125000},"page":"341-347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Philadelphia chromosome\u2013negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort study"],"prefix":"10.1007","volume":"124","author":[{"given":"Shota","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9267-2864","authenticated-orcid":false,"given":"Masahiro","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Ara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Kanaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Wakasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuto","family":"Miyagishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toma","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Saga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Kakinoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Oyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"6","key":"4212_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ajh.25792","volume":"95","author":"E Jabbour","year":"2020","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring. Am J Hematol. 2020;95(6):691\u2013709. https:\/\/doi.org\/10.1002\/ajh.25792.","journal-title":"Am J Hematol"},{"issue":"10","key":"4212_CR2","doi-asserted-by":"publisher","first-page":"e7661","DOI":"10.1371\/journal.pone.0007661","volume":"4","author":"X Zheng","year":"2009","unstructured":"Zheng X, Oancea C, Henschler R, Moore MA, Ruthardt M. Reciprocal t(9;22) ABL\/BCR fusion proteins: leukemogenic potential and effects on B cell commitment. PLoS ONE. 2009;4(10):e7661. https:\/\/doi.org\/10.1371\/journal.pone.0007661.","journal-title":"PLoS ONE"},{"issue":"9","key":"4212_CR3","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00432-011-1002-4","volume":"137","author":"A Bennour","year":"2011","unstructured":"Bennour A, Bellaaj H, Ben Youssef Y, Elloumi M, Khelif A, Saad A, et al. Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients. J Cancer Res Clin Oncol. 2011;137(9):1329\u201336. https:\/\/doi.org\/10.1007\/s00432-011-1002-4.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"4212_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0165-4608(88)90244-0","volume":"35","author":"ME Weinstein","year":"1988","unstructured":"Weinstein ME, Grossman A, Perle MA, Wilmot PL, Verma RS, Silver RT, et al. The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemia. Cancer Genet Cytogenet. 1988;35(2):223\u20139. https:\/\/doi.org\/10.1016\/0165-4608(88)90244-0.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"4212_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cancergencyto.2003.08.018","volume":"150","author":"A Zagaria","year":"2004","unstructured":"Zagaria A, Anelli L, Albano F, Storlazzi CT, Liso A, Roberti MG, et al. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome. Cancer Genet Cytogenet. 2004;150(1):81\u20135. https:\/\/doi.org\/10.1016\/j.cancergencyto.2003.08.018.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"4212_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0165-4608(90)90031-5","volume":"47","author":"H Zitzelsberger","year":"1990","unstructured":"Zitzelsberger H, Bauchinger M, Wilmanns W, Strauss PG. Cytogenetic and molecular analysis of a \u201cmasked\u201d Philadelphia chromosome in chronic and blastic phases of chronic myeloid leukemia. Cancer Genet Cytogenet. 1990;47(2):219\u201325. https:\/\/doi.org\/10.1016\/0165-4608(90)90031-5.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"4212_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0165-4608(89)90046-0","volume":"37","author":"PJ Browett","year":"1989","unstructured":"Browett PJ, Cooke HM, Secker-Walker LM, Norton JD. Chromosome 22 breakpoints in variant Philadelphia translocations and Philadelphia-negative chronic myeloid leukemia. Cancer Genet Cytogenet. 1989;37(2):169\u201377. https:\/\/doi.org\/10.1016\/0165-4608(89)90046-0.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"4212_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0165-4608(87)90110-5","volume":"24","author":"K Ohyashiki","year":"1987","unstructured":"Ohyashiki K, Ohyashiki JH, Otaki K, Yoshida MA, Raza A, Preisler HD, et al. Four cases with complex Philadelphia translocations, including one with appearance de novo of a \u201cmasked\u201d Ph. Cancer Genet Cytogenet. 1987;24(2):281\u201394. https:\/\/doi.org\/10.1016\/0165-4608(87)90110-5.","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"4212_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0165-4608(83)90074-2","volume":"8","author":"M Sessarego","year":"1983","unstructured":"Sessarego M, Pasquali F, Bianchi Scarra GL, Ajmar F. Masked Philadelphia chromosome caused by translocation (9;11;22). Cancer Genet Cytogenet. 1983;8(4):319\u201323. https:\/\/doi.org\/10.1016\/0165-4608(83)90074-2.","journal-title":"Cancer Genet Cytogenet"},{"key":"4212_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13039-015-0204-x","volume":"8","author":"A Wafa","year":"2015","unstructured":"Wafa A, Almedani S, Liehr T, Al-Achkar W. Masked inv dup(22)(q11.23), tetrasomy 8 and trisomy 19 in a blast crisis-chronic myeloid leukemia after interrupted Imatinib-treatment. Mol Cytogenet. 2015;8:98. https:\/\/doi.org\/10.1186\/s13039-015-0204-x.","journal-title":"Mol Cytogenet"},{"key":"4212_CR11","doi-asserted-by":"publisher","first-page":"691630","DOI":"10.1155\/2014\/691630","volume":"2014","author":"F Malvestiti","year":"2014","unstructured":"Malvestiti F, Agrati C, Chinetti S, Di Meco A, Cirrincione S, Oggionni M, et al. Complex variant of Philadelphia translocation involving chromosomes 9, 12, and 22 in a case with chronic myeloid leukaemia. Case Rep Genet. 2014;2014:691630. https:\/\/doi.org\/10.1155\/2014\/691630.","journal-title":"Case Rep Genet"},{"issue":"7","key":"4212_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/s0145-2126(98)00058-7","volume":"22","author":"AL Shanske","year":"1998","unstructured":"Shanske AL, Grunwald H, Cook P, Heisterkamp N, Groffen J. Philadelphia-negative chronic myelogenous leukemia in a patient with a unique complex translocation: 46,XY,t(9;12;15)(q34;12;q21). Leuk Res. 1998;22(7):645\u20138. https:\/\/doi.org\/10.1016\/s0145-2126(98)00058-7.","journal-title":"Leuk Res"},{"issue":"11","key":"4212_CR13","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s00277-023-05405-0","volume":"102","author":"H Kimura","year":"2023","unstructured":"Kimura H, Onozawa M, Yoshida S, Miyashita N, Yokoyama S, Matsukawa T, et al. Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia. Ann Hematol. 2023;102(11):3103\u201313. https:\/\/doi.org\/10.1007\/s00277-023-05405-0.","journal-title":"Ann Hematol"},{"issue":"3","key":"4212_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48(3):452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"4212_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2141.1995.tb03311.x","volume":"89","author":"PE Devaraj","year":"1995","unstructured":"Devaraj PE, Foroni L, Kitra-Roussos V, Secker-Walker LM. Detection of BCR-ABL and E2A-PBX1 fusion genes by RT-PCR in acute lymphoblastic leukaemia with failed or normal cytogenetics. Br J Haematol. 1995;89(2):349\u201355. https:\/\/doi.org\/10.1111\/j.1365-2141.1995.tb03311.x.","journal-title":"Br J Haematol"},{"issue":"11","key":"4212_CR16","first-page":"1110","volume":"44","author":"K Maki","year":"2003","unstructured":"Maki K, Nakamura F, Gunji H, Arai Y, Mitani K. [Philadelphia chromosome-positive acute lymphoblastic leukemia showing normal karyotype at presentation]. Rinsho Ketsueki. 2003;44(11):1110\u20132.","journal-title":"Rinsho Ketsueki"},{"issue":"1","key":"4212_CR17","first-page":"35","volume":"85","author":"M Sessarego","year":"2000","unstructured":"Sessarego M, Fugazza G, Bruzzone R, Ballestrero A, Miglino M, Bacigalupo A. Complex chromosome rearrangements may locate the bcr\/abl fusion gene sites other than 22q11. Haematologica. 2000;85(1):35\u20139.","journal-title":"Haematologica"},{"issue":"2","key":"4212_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0165-4608(93)90176-m","volume":"70","author":"Z Chen","year":"1993","unstructured":"Chen Z, Morgan R, Berger CS, Pearce-Birge L, Stone JF, Sandberg AA. Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr\/abl cosmid probes. Cancer Genet Cytogenet. 1993;70(2):103\u20137. https:\/\/doi.org\/10.1016\/0165-4608(93)90176-m.","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"4212_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/leu.2009.93","volume":"23","author":"F Weerkamp","year":"2009","unstructured":"Weerkamp F, Dekking E, Ng YY, van der Velden VH, Wai H, Bottcher S, et al. Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients. Leukemia. 2009;23(6):1106\u201317. https:\/\/doi.org\/10.1038\/leu.2009.93.","journal-title":"Leukemia"},{"issue":"3","key":"4212_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/ajh.26816","volume":"98","author":"H Kantarjian","year":"2023","unstructured":"Kantarjian H, Short NJ, Jain N, Sasaki K, Huang X, Haddad FG, et al. Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. Am J Hematol. 2023;98(3):493\u2013501. https:\/\/doi.org\/10.1002\/ajh.26816.","journal-title":"Am J Hematol"},{"issue":"1","key":"4212_CR21","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1016\/S2352-3026(22)00319-2","volume":"10","author":"E Jabbour","year":"2023","unstructured":"Jabbour E, Short NJ, Jain N, Huang X, Montalban-Bravo G, Banerjee P, et al. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial. Lancet Haematol. 2023;10(1):e24\u201334. https:\/\/doi.org\/10.1016\/S2352-3026(22)00319-2.","journal-title":"Lancet Haematol"},{"key":"4212_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-025-04058-1","author":"S Nishiwaki","year":"2025","unstructured":"Nishiwaki S, Sugiura I, Fujisawa S, Hatta Y, Atsuta Y, Doki N, et al. Dasatinib is superior to imatinib in adult Ph\u2009+ ALL: a propensity score-matched analysis of pooled JALSG trial data. Int J Hematol. 2025. https:\/\/doi.org\/10.1007\/s12185-025-04058-1.","journal-title":"Int J Hematol"},{"issue":"6","key":"4212_CR23","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s12185-021-03094-x","volume":"113","author":"Y Akahoshi","year":"2021","unstructured":"Akahoshi Y, Arai Y, Nishiwaki S, Mizuta S, Marumo A, Uchida N, et al. Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J Hematol. 2021;113(6):832\u20139. https:\/\/doi.org\/10.1007\/s12185-021-03094-x.","journal-title":"Int J Hematol"},{"issue":"1","key":"4212_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/ajh.27516","volume":"100","author":"H Liu","year":"2025","unstructured":"Liu H, Xu H, Chi P, Feng Z, Xu X, Nie D, et al. A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph(+) acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: a prospective multicenter cohort study. Am J Hematol. 2025;100(1):33\u20137. https:\/\/doi.org\/10.1002\/ajh.27516.","journal-title":"Am J Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04212-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04212-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04212-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:56:08Z","timestamp":1788184568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04212-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4212"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04212-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}